UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes engineered cancer-fighting immune cells behave more like stem cells, improving their therapeutic effectiveness. The study suggests new strategies for improving the efficacy of these immune cells, known as chimeric antigen receptor T cells.
Large pieces of DNA can transfer directly between human cells, and the DNA can persist and change how the recipient cell functions, according to a study led by researchers at Children’s Medical Center Research Institute at UT Southwestern.
